Vita Pure Inc

CLOSEOUT LETTER Vita Pure Inc MARCS-CMS 524473 — January 14, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Dietary Supplements Recipient: Recipient Name Mr. Achyut Sahasra Recipient Title President and Owner Vita Pure Inc 410 West 1st Avenue Roselle , NJ 07203 United States Issuing Office: Baltimore District Office United States Dear Mr. Sahasra: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter issued on November 8, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Andrew Ciaccia Compliance Officer Human and Animal Food East, Division II Content current as of: 03/16/2021 Regulated Product(s) Dietary Supplements